LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 22, Pages 2932-2947
Publisher
Springer Nature
Online
2015-09-21
DOI
10.1038/onc.2015.345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
- (2015) Christine Mehner et al. Oncotarget
- Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
- (2014) Lyndsay V. Rhodes et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
- (2014) D Lindquist et al. BRITISH JOURNAL OF CANCER
- Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer
- (2014) P. A. Thompson et al. CANCER RESEARCH
- Architecture of tight junctions and principles of molecular composition
- (2014) Christina M. Van Itallie et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Membrane-Initiated Estradiol Signaling of Epithelial-Mesenchymal Transition-Associated Mechanisms Through Regulation of Tight Junctions in Human Breast Cancer Cells
- (2014) Javier E. Jiménez-Salazar et al. Hormones & Cancer
- Basal-Like Breast Cancer: Update on Clinicopathologic, Immunohistochemical, and Molecular Features
- (2013) Jennifer Leidy et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
- (2013) Y Wang et al. BRITISH JOURNAL OF CANCER
- C-Met in invasive breast cancer
- (2013) Colan M. Ho-Yen et al. CANCER
- CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression
- (2013) Yunshan Wang et al. CANCER RESEARCH
- Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways
- (2013) Jaemoo Chun et al. CHEMICO-BIOLOGICAL INTERACTIONS
- MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
- (2013) Yu Jin Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Leucine-rich Repeat and Immunoglobulin Domain-containing Protein-1 (Lrig1) Negative Regulatory Action toward ErbB Receptor Tyrosine Kinases Is Opposed by Leucine-rich Repeat and Immunoglobulin Domain-containing Protein 3 (Lrig3)
- (2013) Hanine Rafidi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis
- (2013) Takahiro Nakamura et al. JOURNAL OF CLINICAL INVESTIGATION
- Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
- (2013) Lei Chang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling
- (2013) J J-C Sheu et al. ONCOGENE
- Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
- (2013) Veronica Rondahl et al. PLoS One
- Molecular insights on basal-like breast cancer
- (2012) Mev Dominguez Valentin et al. BREAST CANCER RESEARCH AND TREATMENT
- Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
- (2012) N. P. A. Devika Gunasinghe et al. CANCER AND METASTASIS REVIEWS
- LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNF Expression and Receptor Tyrosine Kinase Signaling
- (2012) L. Bai et al. CANCER RESEARCH
- Suppression of the Epithelial-Mesenchymal Transition by Grainyhead-like-2
- (2012) B. Cieply et al. CANCER RESEARCH
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development
- (2012) Liwen Lu et al. JOURNAL OF PATHOLOGY
- c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
- (2012) Lucia Knopfová et al. Molecular Cancer
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling
- (2012) Vivian W. Y. Wong et al. NATURE CELL BIOLOGY
- Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody
- (2012) J M Lee et al. ONCOGENE
- Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma
- (2012) Young Chang Lim et al. ORAL ONCOLOGY
- The T Box Transcription Factor TBX2 Promotes Epithelial-Mesenchymal Transition and Invasion of Normal and Malignant Breast Epithelial Cells
- (2012) Bin Wang et al. PLoS One
- Met Receptor Acts Uniquely for Survival and Morphogenesis of EGFR-Dependent Normal Mammary Epithelial and Cancer Cells
- (2012) Paolo Accornero et al. PLoS One
- Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway
- (2012) Pei-Chien Tsai et al. TOXICON
- A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
- (2012) Robin M. Hallett et al. Scientific Reports
- bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
- (2011) Pascal Jézéquel et al. BREAST CANCER RESEARCH AND TREATMENT
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- Synergistic Effects of Foretinib with HER-Targeted Agents in MET and HER1- or HER2-Coactivated Tumor Cells
- (2011) L. Liu et al. MOLECULAR CANCER THERAPEUTICS
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
- (2011) Irina M. Shapiro et al. PLoS Genetics
- Identifying common prognostic factors in genomic cancer studies: A novel index for censored outcomes
- (2010) Sigrid Rouam et al. BMC BIOINFORMATICS
- Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
- (2010) F. Hochgrafe et al. CANCER RESEARCH
- The Met receptor tyrosine kinase and basal breast cancer
- (2010) Marisa G. Ponzo et al. CELL CYCLE
- Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
- (2010) Chad J. Creighton et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
- (2010) Yvonne L Chao et al. Molecular Cancer
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to Therapies
- (2010) Cristina Marchini et al. PLoS One
- Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
- (2009) H Nalwoga et al. BRITISH JOURNAL OF CANCER
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
- (2009) Kim B. Jensen et al. Cell Stem Cell
- Epidermal stem cell diversity and quiescence
- (2009) Fiona M. Watt et al. EMBO Molecular Medicine
- Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
- (2009) M. G. Ponzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
- (2008) J. K. Miller et al. CANCER RESEARCH
- Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
- (2008) A. J. Trimboli et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF
- (2008) F. Ledda et al. JOURNAL OF NEUROSCIENCE
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now